BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 15, 2017
View Archived Issues
Alligator begins preclinical development of ATOR-1017 for metastasizing cancer
Read More
First-in-human results on PET imaging of dopamine transporter with [18F]LBT-999
Read More
ETX-0282/cefpodoxime proxetil combination shows promise against resistant Gram-negative uropathogens
Read More
Full OlympiAD results show benefit of PARP inhibition with olaparib in breast cancer
Read More
Cefepime/S-02030 combination efficacious in murine bacteremia model
Read More
Domainex expands MAP4K4 inhibitor partnership with Imperial College London
Read More
BioTime's pivotal European trial of Renevia meets primary endpoint
Read More
Long-term data from phase I/II data of GS-010 in Leber's hereditary optic neuropathy
Read More
Actelion presents preclinical data for novel bacterial topoisomerase inhibitor ACT-051
Read More
Aldeyra reports phase IIb results for ADX-102 in allergic conjunctivitis
Read More
ACEA completes phase I trial of AC-0058
Read More
Takara Bio initiates phase I/II study of TBI-1501 for relapsed or refractory ALL
Read More
Janssen begins first-in-human study of JNJ-64007957 for relapsed or refractory multiple myeloma
Read More
Leids Universitair Medisch Centrum presents recombinant serine protease variants
Read More
Adaptimmune and Immunocore identify TRPM1 derivatives
Read More
Lilly initiates phase I study of LY-3325656 for type 2 diabetes
Read More
Cancer Research Technology and AstraZeneca divulge GLS inhibitors
Read More
SBIR grant supports Hillhurst's development of HBI-002 to prevent delayed graft function
Read More
Chiesi Farmaceutici discloses muscarinic M3 receptor antagonists and beta2-adrenoceptor agonists
Read More
Tirabrutinib granted FDA orphan drug designation for chronic lymphocytic leukemia
Read More
Novartis discloses Janus kinase inhibitors
Read More
REGN-1979 receives U.S. orphan drug designation for diffuse large B-cell lymphoma
Read More
Amylyx initiates phase II trial of AMX-0035 in ALS
Read More
Abivax to receive loan to support development of Ebola hyperimmune candidate
Read More
MedImmune initiates phase I trial of MEDI-3506 for COPD
Read More
Pfizer gains European commercialization rights to Cresemba from Basilea
Read More
TiGenix partners with Crohn's disease and ulcerative colitis patient advocacy groups
Read More
LGCL-1, a novel FFA4 receptor agonist for treating metabolic disorders
Read More